Advertisement

Topics

Bioverativ's IND for sickle cell disease drug accepted by FDA

06:04 EDT 17 May 2018 | SmartBrief

The FDA accepted Bioverativ's investigative new drug application for BIVV003 as a treatment for sickle cell disease.  -More

Original Article: Bioverativ's IND for sickle cell disease drug accepted by FDA

NEXT ARTICLE

More From BioPortfolio on "Bioverativ's IND for sickle cell disease drug accepted by FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...